Evogene logo

Evogene Share Price (NASDAQ: EVGN)

$1.38

0.03

(2.22%)

Live

Last updated on

Check the interactive Evogene Stock chart to analyse performance

Evogene stock performance

as on August 18, 2025 at 11:40 PM IST

  • Today's Low:$1.37
    Today's High:$1.40

    Day's Volatility :2.14%

  • 52 Weeks Low:$0.95
    52 Weeks High:$4.17

    52 Weeks Volatility :77.2%

Evogene Stock Returns

PeriodEvogene LtdIndex (Russel 2000)
3 Months
0.75%
0.0%
6 Months
-8.78%
0.0%
1 Year
-65.79%
0.0%
3 Years
-88.75%
-11.6%

Evogene Ltd Key Stats

Check Evogene key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.35
Open
$1.33
Today's High
$1.4
Today's Low
$1.37
Market Capitalization
$11.8M
Today's Volume
$39.4K
52 Week High
$4.166
52 Week Low
$0.95
Revenue TTM
$6.8M
EBITDA
$-21.2M
Earnings Per Share (EPS)
$-2.51
Profit Margin
-224.82%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-91.05%

Stock Returns calculator for Evogene Stock including INR - Dollar returns

The Evogene stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Evogene investment value today

Current value as on today

₹39,010

Returns

₹60,990

(-60.99%)

Returns from Evogene Stock

₹65,063 (-65.06%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Evogene Stock

-27%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Evogene Stock from India on INDmoney has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Evogene Ltd

  • Name

    Holdings %

  • Armistice Capital, LLC

    3.63%

  • Jane Street Group LLC

    0.39%

  • UBS Group AG

    0.22%

  • Morgan Stanley - Brokerage Accounts

    0.17%

  • BNP Paribas Arbitrage, SA

    0.16%

  • TWO SIGMA SECURITIES, LLC

    0.16%

Analyst Recommendation on Evogene Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Evogene(by analysts ranked 0 to 5 stars)

Evogene Share Price Target

What analysts predicted

Upside of 153.62%

Target:

$3.50

Current:

$1.38

Evogene share price target is $3.50, a slight Upside of 153.62% compared to current price of $1.38 as per analysts' prediction.

Evogene Stock Insights

  • Price Movement

    In the last 7 days, EVGN stock has moved up by 11.6%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.61M → 2.44M (in $), with an average increase of 34.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 427.0K → -2.58M (in $), with an average decrease of 705.9% per quarter
  • EVGN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 134.9%
  • EVGN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 100.9% return, outperforming this stock by 190.0%
  • Price to Sales

    ForEVGN every $1 of sales, investors are willing to pay $1.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.6 for every $1 of sales.

Evogene Ltd Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$8.5M
↑ 50.9%
Net Income
$-16.5M
↓ 30.96%
Net Profit Margin
-193.69%
↑ 229.7%

Evogene Technicals Summary

Sell

Neutral

Buy

Evogene is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Evogene Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Evogene Ltd logo
4.65%
-8.78%
-65.79%
-88.75%
-90.22%
Regeneron Pharmaceuticals, Inc. logo
6.39%
-14.65%
-51.51%
-6.14%
-7.82%
Beone Medicines Ltd logo
10.08%
34.96%
66.94%
83.8%
36.85%
Vertex Pharmaceuticals Incorporated logo
-14.33%
-15.0%
-19.52%
31.35%
45.44%
Alnylam Pharmaceuticals, Inc. logo
40.06%
79.56%
63.55%
107.86%
227.15%

About Evogene Ltd

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.
Organization
Evogene
Employees
117
CEO
Mr. Amit Noam Capt. res.
Industry
Health Technology

Key Management of Evogene Ltd

NameTitle
Mr. Ofer Haviv CPA
CEO, President & Director
Dr. Elran Hillel Haber M.B.A., Ph.D.
Chief Executive Officer of Biomica Ltd
Mr. Yoash Zohar
Chief Executive Officer of Casterra Ag Ltd.
Dr. Dan Jacob Gelvan Ph.D.
Chief Executive Officer of Ag Plenus Ltd.
Mr. Amit Noam Capt. res.
Chief Executive Officer of Lavie Bio Ltd.
Mr. Yaron Eldad
Chief Financial Officer
Ms. Liat Foigel Wejgman
Vice President of Human Resources
Mr. Russ Putland
Executive VP Commercial & General Manager USA

Important FAQs about investing in EVGN Stock from India :

What is Evogene share price today?

Evogene share price today is $1.38 as on . Evogene share today touched a day high of $1.40 and a low of $1.37.

What is the 52 week high and 52 week low for Evogene share?

Evogene share touched a 52 week high of $4.17 and a 52 week low of $0.95. Evogene stock price today, is trending at $1.38, lower by 66.87% versus the 52 week high.

How to invest in Evogene Stock (EVGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evogene on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evogene Shares that will get you 1.0870 shares as per Evogene share price of $1.38 per share as on August 18, 2025 at 11:40 PM IST.

What is the minimum amount required to buy Evogene Stock (EVGN) from India?

Indian investors can start investing in Evogene (EVGN) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Evogene stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Evogene share’s latest price of $1.38 as on August 18, 2025 at 11:40 PM IST, you will get 7.2464 shares of Evogene. Learn more about fractional shares .

What are the returns that Evogene has given to Indian investors in the last 5 years?

Evogene stock has given -90.22% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?